Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.07T
Market cap1.07T
Price-Earnings ratio
40.73
Price-Earnings ratio40.73
Dividend yield
0.57%
Dividend yield0.57%
Average volume
3.42M
Average volume3.42M
High today
$1,166.29
High today$1,166.29
Low today
$1,111.00
Low today$1,111.00
Open price
$1,143.39
Open price$1,143.39
Volume
4.13M
Volume4.13M
52 Week high
$1,166.29
52 Week high$1,166.29
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 1.07T, Eli Lilly(LLY) trades at $1,123.00. The stock has a price-to-earnings ratio of 40.73 and currently yields dividends of 57.1%.

On 2026-06-07, Eli Lilly(LLY) stock moved within a range of $1,111.00 to $1,166.29. With shares now at $1,123.00, the stock is trading +1.1% above its intraday low and -3.7% below the session's peak.

Trading activity shows a volume of 4.13M, compared to an average daily volume of 3.42M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,166.29 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,166.29 and a low of $623.78.

LLY News

Nasdaq 4h
Lilly's Foundayo Demonstrates Weight Loss Across Menopause Stages

(RTTNews) - Eli Lilly and Company (LLY) announced new results showing that women with obesity or overweight who took the highest dose of Foundayo achieved signi...

Lilly's Foundayo Demonstrates Weight Loss Across Menopause Stages
TipRanks 8h
Eli Lilly’s New Drug Gives Investors a Wake-Up Call as Data Bolsters the Stock’s Growth Story - TipRanks

...

Eli Lilly’s New Drug Gives Investors a Wake-Up Call as Data Bolsters the Stock’s Growth Story - TipRanks
TipRanks 8h
Eli Lilly’s Retatrutide Gives LLY Stock a Fresh Obesity Drug Catalyst

Eli Lilly and Company (LLY) gave investors another reason to watch its obesity pipeline after new late-stage data showed that its experimental drug retatrutide...

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

Nasdaq 24h
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing

Key Points Eli Lilly is probably best known for its dominant GLP-1 drugs right now. The company's recent $3.8 billion investment in the vaccine space is more...

Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing
Nasdaq 1d
Prediction: Eli Lilly Will Reach $1,200 in 2026

Key Points Eli Lilly now controls roughly 60% of the GLP-1 market. International growth could become Lilly's next major catalyst. The GLP-1 franchise could r...

Prediction: Eli Lilly Will Reach $1,200 in 2026
TipRanks 2d
Lilly Expands Obesity Pipeline With New Phase 2b Macupatide–Eloralintide Trial

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analys...

Nasdaq 2d
CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors

Key Points CVS Caremark will cover Eli Lilly's weight loss medicines. This decision could help boost the drugmaker's sales. Eli Lilly's prospects remain attr...

CVS Health Just Announced Fantastic News to Eli Lilly Stock Investors
Zacks 3d
Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart

Thursday, June 4, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports o...

Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart
TipRanks 3d
Lilly’s ATTAIN-MAINTAIN Trial: A Fresh Pill-Based Play in the Obesity Market

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analys...

Benzinga 3d
Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies

• Eli Lilly stock is surging to new heights today. What’s driving LLY stock higher? Weight Watchers Expands GLP-1 Access Through LillyDirect The addition to L...

Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.